Rhythm Biosciences Ltd (ASX: RHY) Share Price and News
Price
$0.054
Movement
0.003 (+5.88%)
as at 3 Jul 10:03am (20 mins delayed)
52 Week Range
$0.042 - $0.14
1 Year Return
-11.48%
Rhythm Biosciences Ltd Chart and Price Data
Fundamentals Data provided by Morningstar.
Data provided by Morningstar.Share Price
$0.054
Day Change
0.003 (+5.88%)
52 Week Range
$0.042 - $0.14
Yesterday's Close
$0.051
Today's Open
$0.054
Days Range
$0.054 - $0.054
Volume
21,691
Avg. Volume (1 month)
434,765
Turnover
$1,171
as at 3 Jul 10:03am
Rhythm Biosciences Ltd (ASX: RHY)
Latest News

Healthcare Shares
2 ASX healthcare shares racing higher on positive updates

Healthcare Shares
ASX All ords biotech stock explodes 120% on regulatory green light

Share Market News
Guess which ASX All Ords share just crashed 52% on a TGA update

Share Gainers
It's not all bad news for ASX All Ords shares today. Here are some big winners

Healthcare Shares
2 ASX healthcare shares smashing the All Ords today

Healthcare Shares
The chair of this ASX All Ords company just sold $6.5 million of shares. What gives?

Healthcare Shares
Rhythm Biosciences share price lifts 5% on TGA news

Healthcare Shares
Here's why the Rhythm Biosciences (ASX:RHY) share price soared 8% today

Healthcare Shares
Here's why the Rhythm (ASX:RHY) share price is up 11% today

Healthcare Shares
Rhythm Biosciences (ASX:RHY) share price roars 8% on new cancer markets

Healthcare Shares
Rhythm Biosciences (ASX: RHY) share price slumps amid 'pivotal' board changes

Share Gainers
Rhythm Biosciences (ASX:RHY) share price rockets amid US$12bn market opportunity
RHY ASX Announcements
An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.
Date | Announcement | Price Sensitive? | Time | No. of Pages | File Size |
---|---|---|---|---|---|
30th Jun 2025 2025-06-30T17:28:45 | FY2025 R&D Tax Incentive Loan Funding | YesNo | 5:28pm | 2 | 8.2M |
24th Jun 2025 2025-06-24T09:16:59 | NATA Accreditation Awarded for Genetype Laboratory | YesNo | 9:16am | 2 | 468k |
23rd Jun 2025 2025-06-23T16:35:43 | Ceasing to be a substantial holder | YesNo | 4:35pm | 2 | 574k |
23rd Jun 2025 2025-06-23T09:09:55 | Board Composition Update Succession Plan | YesNo | 9:09am | 3 | 8.2M |
19th Jun 2025 2025-06-19T09:12:04 | Overview of Genetype Presentation | YesNo | 9:12am | 30 | 2.9M |
11th Jun 2025 2025-06-11T09:08:15 | Genetype Publication Market Update | YesNo | 9:08am | 2 | 408k |
10th Jun 2025 2025-06-10T17:26:34 | Change in substantial holding - Michelle Wing | YesNo | 5:26pm | 3 | 428k |
2nd Jun 2025 2025-06-02T15:20:53 | Cleansing Notice | YesNo | 3:20pm | 2 | 366k |
2nd Jun 2025 2025-06-02T15:06:43 | Application for quotation of securities - RHY | YesNo | 3:06pm | 6 | 16k |
2nd Jun 2025 2025-06-02T09:07:56 | Investor Presentation | YesNo | 9:07am | 17 | 1.6M |
About Rhythm Biosciences Ltd
Rhythm Biosciences Ltd is a medical diagnostics technology company. It is engaged in developing and commercializing Australian medical diagnostics technology for sale to national and international markets. Its product includes ColoSTAT a proposed diagnostic blood test for screening for colorectal cancer. The company operates predominantly in one business and geographical segment which is the research and development of biosciences in Australia.
RHY Share Price History Data provided by Morningstar.
Date | Close | Change | % Change | Volume | Open | High | Low |
---|---|---|---|---|---|---|---|
01 Jul 2025 | $0.05 | $0.00 | 0.00% | 1,944,179 | $0.06 | $0.06 | $0.05 |
30 Jun 2025 | $0.05 | $0.00 | 0.00% | 740,853 | $0.06 | $0.06 | $0.05 |
27 Jun 2025 | $0.06 | $0.00 | 0.00% | 616,457 | $0.06 | $0.06 | $0.06 |
26 Jun 2025 | $0.06 | $0.00 | 0.00% | 361,669 | $0.06 | $0.06 | $0.06 |
25 Jun 2025 | $0.06 | $0.00 | 0.00% | 511,027 | $0.06 | $0.06 | $0.06 |
24 Jun 2025 | $0.06 | $0.00 | 0.00% | 1,103,992 | $0.06 | $0.06 | $0.06 |
23 Jun 2025 | $0.06 | $0.00 | 0.00% | 339,372 | $0.06 | $0.06 | $0.06 |
20 Jun 2025 | $0.06 | $0.00 | 0.00% | 573,318 | $0.06 | $0.07 | $0.06 |
19 Jun 2025 | $0.07 | $0.01 | 16.67% | 436,097 | $0.06 | $0.07 | $0.06 |
18 Jun 2025 | $0.06 | $0.00 | 0.00% | 136,183 | $0.06 | $0.06 | $0.06 |
17 Jun 2025 | $0.06 | $0.00 | 0.00% | 533,192 | $0.06 | $0.06 | $0.06 |
16 Jun 2025 | $0.06 | $0.00 | 0.00% | 61,022 | $0.06 | $0.06 | $0.06 |
13 Jun 2025 | $0.06 | $0.00 | 0.00% | 196,507 | $0.06 | $0.06 | $0.06 |
12 Jun 2025 | $0.06 | $0.00 | 0.00% | 382,633 | $0.06 | $0.06 | $0.06 |
11 Jun 2025 | $0.06 | $0.00 | 0.00% | 173,677 | $0.06 | $0.06 | $0.06 |
10 Jun 2025 | $0.06 | $0.00 | 0.00% | 452,883 | $0.06 | $0.06 | $0.06 |
06 Jun 2025 | $0.06 | $0.00 | 0.00% | 64,239 | $0.06 | $0.06 | $0.06 |
05 Jun 2025 | $0.06 | $0.00 | 0.00% | 53,779 | $0.06 | $0.06 | $0.06 |
04 Jun 2025 | $0.06 | $0.00 | 0.00% | 269,207 | $0.06 | $0.06 | $0.06 |
03 Jun 2025 | $0.06 | $0.00 | 0.00% | 18,895 | $0.06 | $0.06 | $0.06 |
Director Transactions Data provided by Morningstar.
Date | Director | Type | Amount | Value | Notes |
---|---|---|---|---|---|
31 Jul 2024 | Otto Buttula | Expiry | 1,342,500 | $71,152 |
Options expired.
|
31 Jul 2024 | Louis (Lou) Panaccio | Expiry | 85,000 | $4,505 |
Options expired.
|
31 Jul 2024 | Trevor Lockett | Expiry | 252,000 | $13,356 |
Options expired.
|
Directors & Management Data provided by Morningstar.
Name | Title | Start Date | Profile |
---|---|---|---|
Mr Otto Leslie Steven Buttula | Executive ChairmanExecutive Director | Oct 2019 |
Mr Buttula has had experience and success in investment research, funds management, information and biotechnologies and has held directorships in a number of public companies. Mr Buttula's executive experience includes co-founder and CEO and Managing Director of IWL Ltd, an online financial services company that listed on the ASX in 1999. Mr Buttula also founded and was Managing Director of Investors Mutual, prior to which he was a co-founder and director of Lonsdale Securities Ltd.
|
Dr David Atkins | Chief Executive OfficerManaging Director | May 2024 |
--
|
Mr Gavin Fox-Smith | Non-Executive Director | Dec 2024 |
Mr Fox-Smith has been a leader and champion of Medical Technology across Australia/NZ and Asia. He has also played lead Governance and Executive roles in Industry Bodies, Innovation Initiatives and Not for Profit Boards. Gavin is advocate for Gender Equality and Indigenous Engagement. His career spans over 35 years, previously holding the position of Managing Director Australia/NZ and Vice President Asia Pacific for Johnson & Johnson Medical Devices, Chair of the Medical Technology Association of Australia, Governor of American Chamber of Commerce, Co-Founder/Chair of Macquarie Park Business Coalition (in partnership with United Way) and Australian Co-Chair of the Health Technology Sector Group of the Australia/NZ Leadership Forum. Gavin is currently transitioning out of his executive CEO role at Omnigon, a private Australian company in the Ostomy Care market. He is currently, Chair of ANDHealth (Australias National Digital Health Initiative), Board Director for Bowel Cancer Australia and Board Director for SAN Foundation. Gavin is a member of the Champions of Change Coalition STEM/Health group and serves as Ambassador for Rotary Oceania Medical Aid for Children (ROMAC).
|
Ms Andrea Steele | Company SecretaryGeneral Counsel | Feb 2022 |
-
|
Mr James Stephen Barrie | Joint Company Secretary | Dec 2023 |
-
|
Andrea Steele | Company SecretaryGeneral Counsel |
-
|
|
Guy Carisbrooke | Financial Controller |
-
|
|
James Stephen Barrie | Joint Company Secretary |
-
|
Top Shareholders Data provided by Morningstar.
Name | Shares | Capital |
---|---|---|
Webinvest Pty Ltd | 22,479,168 | 9.04% |
Newfound Investments Pty Ltd | 13,905,407 | 5.59% |
Ferndale Securities Pty Ltd | 10,300,000 | 4.14% |
HSBC Custody Nominees (Australia) Limited | 9,269,796 | 3.73% |
Loumea Investment Pty Ltd | 8,052,520 | 3.24% |
Northern Star Nominees Pty Ltd | 7,380,000 | 2.97% |
Rojo Nero Capital Pty Ltd | 4,213,751 | 1.70% |
Giokir Pty Ltd | 3,661,470 | 1.47% |
Mr Hsien Michael Soo | 3,305,403 | 1.33% |
Mr Mark Anthony Rogers & Mr Arthur Nicholas Veliss | 3,000,000 | 1.21% |
DC & PC Holdings Pty Ltd | 2,688,156 | 1.08% |
Commonwealth Scientific & Industrial Research Organisation | 2,500,000 | 1.01% |
Ms Natalie Louise Patterson | 2,477,083 | 1.00% |
E & W Nominee Pty Ltd | 2,207,941 | 0.89% |
Mr Daniel Eddington & Mrs Julie Eddington | 2,123,532 | 0.85% |
Mr Wei Feng & Mrs Jie Liu | 2,050,215 | 0.82% |
Mrs Joan Margaret Molyneux & Mrs Wendy Anne Hutchison & Mr John Edward Hutchison | 2,000,000 | 0.80% |
Ardroy Securities Pty Ltd | 1,857,040 | 0.75% |
BNP Paribas Nominees Pty Ltd ACF Clearstream | 1,775,214 | 0.71% |
Mrs Linda Jane Lockett & Dr Trevor John Lockett | 1,678,300 | 0.68% |